Author:
Melcón Soledad Gallego,de Toledo Codina José Sánchez
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Seeger R, Reynolds C. Treatment of high-risk solid tumors of childhood with intensive therapy and autologous bone marrow transplantation. Pediatr Clin North Am 1991; 38: 393–424.
2. Herzig R, Lazarus H, Graham-Pole J, et al. Autologous bone marrow transplantation for malignant diseases: a phase I–II study for melanoma, neuroblastoma, Ewing’s sarcoma, and germ cell tumors using high-dose melphalan. En: Gale RP, ed. Recent advances in bone marrow transplantatation. New York: Liss, 1983; 643–657.
3. Sánchez de Toledo J, Gallego S, Pérez Payarols J, et al. Melfalán a altas dosis seguido de autotrasplante de médula ósea en tumores sólidos de la infancia. Med Clin 1989; 86: 621–623.
4. Ozkaynak M, Matthay K, Cairo M, et al. Double-alkilator non-total-body irradiation regimen with autologous hematopietic stem-cell transplantation in pediatric solid tumors. J Clin Oncol 1998; 16: 937–944.
5. Kajiume T, Kawano Y, Takaue Y, et al. New consecutive high-dose chemotherapy modality with fractionated blood stem cell support in the treatment of high-risk pediatric solid tumors: a feasibility study. Bone Marrow Transplant 1998; 21: 147–151.